AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$489M |
| 2 |
PayPal
PYPL
|
+$464M |
| 3 |
Dollar General
DG
|
+$438M |
| 4 |
Synopsys
SNPS
|
+$432M |
| 5 |
MSCI
MSCI
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$887M |
| 2 |
Meta Platforms (Facebook)
META
|
+$589M |
| 3 |
Apple
AAPL
|
+$474M |
| 4 |
Nike
NKE
|
+$451M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVA
2501
DELISTED
Enviva Inc.
EVA
| $639K | ﹤0.01% |
12,072
+6
| +0% | +$343 |
|
2502
BioLife Solutions
BLFS
$1.56B
| $635K | ﹤0.01% |
34,878
+49
| +0.1% | +$1.01K |
|
2503
QuantumScape Corp
QS
$3.18B
| $634K | ﹤0.01% |
111,821
+5,064
| +5% | +$37.5K |
|
|
AGEN
2504
Agenus
AGEN
$275M
| $634K | ﹤0.01% |
13,456
| – | – |
|
2505
Compass
COMP
$8.88B
| $632K | ﹤0.01% |
271,400
+11,200
| +4% | +$29.4K |
|
|
DNMR
2506
DELISTED
Danimer Scientific, Inc.
DNMR
| $632K | ﹤0.01% |
8,831
+3,518
| +66% | +$333K |
|
|
NKLA
2507
DELISTED
Nikola Corporation Common Stock
NKLA
| $632K | ﹤0.01% |
9,757
-1,100
| -10% | -$92K |
|
2508
Peoples Bancorp
PEBO
$1.52B
| $631K | ﹤0.01% |
22,349
| – | – |
|
2509
Kiniksa Pharmaceuticals
KNSA
$6.11B
| $628K | ﹤0.01% |
41,900
| – | – |
|
|
BLDP
2510
Ballard Power Systems
BLDP
$808M
| $626K | ﹤0.01% |
130,747
+27,026
| +26% | +$153K |
|
|
CBL
2511
CBL Properties
CBL
$1.86B
| $625K | ﹤0.01% |
27,100
-485
| -2% | -$13.1K |
|
2512
Victory Capital Holdings
VCTR
$6.28B
| $622K | ﹤0.01% |
23,200
+2,400
| +12% | +$67.5K |
|
|
CHS
2513
DELISTED
Chicos FAS, Inc.
CHS
| $622K | ﹤0.01% |
126,462
+68,603
| +119% | +$386K |
|
|
NVSA
2514
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
| $622K | ﹤0.01% |
61,614
-132,036
| -68% | -$1.32M |
|
2515
Anika Therapeutics
ANIK
$202M
| $620K | ﹤0.01% |
20,956
+1,115
| +6% | +$31.7K |
|
|
LICY
2516
DELISTED
Li-Cycle Holdings Corp.
LICY
| $620K | ﹤0.01% |
16,275
| – | – |
|
|
OTLY
2517
Oatly Group
OTLY
$473M
| $616K | ﹤0.01% |
+17,709
| New | +$676K |
|
|
MCHB
2518
Mechanics Bancorp
MCHB
$3.51B
| $616K | ﹤0.01% |
22,325
+1,617
| +8% | +$44.2K |
|
2519
Nordic American Tanker
NAT
$1.35B
| $614K | ﹤0.01% |
200,655
+41,800
| +26% | +$135K |
|
2520
PAR Technology
PAR
$707M
| $613K | ﹤0.01% |
23,500
-1,240
| -5% | -$31.9K |
|
|
RAPT
2521
DELISTED
RAPT Therapeutics
RAPT
| $612K | ﹤0.01% |
3,863
+350
| +10% | +$56K |
|
2522
indie Semiconductor
INDI
$678M
| $611K | ﹤0.01% |
104,800
+34,900
| +50% | +$257K |
|
|
NAPA
2523
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $610K | ﹤0.01% |
36,800
| – | – |
|
|
SPNS
2524
DELISTED
Sapiens International
SPNS
| $610K | ﹤0.01% |
32,986
+1,500
| +5% | +$28.2K |
|
2525
AngioDynamics
ANGO
$593M
| $605K | ﹤0.01% |
43,972
+55
| +0.1% | +$765 |
|
Similar funds
AllianceBernstein's Q4 2022 Portfolio in Review
As of Q4 2022, AllianceBernstein held 3,394 positions worth $222B, up 7.6% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AllianceBernstein's Q4 2022 filing shows 124 new, 1,572 increased, 1,272 reduced and 134 closed positions. Its largest new stake was Unilever: 2,996,697 shares worth $170M. The largest sale was Alphabet (Google) Class C, an estimated $887M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2022 buy was Unilever: 2,996,697 shares worth $170M.
- AllianceBernstein added most to Illumina in Q4 2022, an estimated $489M increase.
- AllianceBernstein's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $887M.
- AllianceBernstein fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $343M.
- AllianceBernstein's ten largest holdings make up 21% of its $222B portfolio in Q4 2022.
- AllianceBernstein opened 124 new positions and closed 134 in Q4 2022.
- AllianceBernstein's portfolio value rose 7.6% quarter-over-quarter to $222B.
Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.